161 related articles for article (PubMed ID: 32060343)
1. Prognostic value of VISTA in solid tumours: a systematic review and meta-analysis.
He XL; Zhou Y; Lu HZ; Li QX; Wang Z
Sci Rep; 2020 Feb; 10(1):2662. PubMed ID: 32060343
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis.
Orhan A; Vogelsang RP; Andersen MB; Madsen MT; Hölmich ER; Raskov H; Gögenur I
Eur J Cancer; 2020 Jun; 132():71-84. PubMed ID: 32334338
[TBL] [Abstract][Full Text] [Related]
3. VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma.
Zhang M; Pang HJ; Zhao W; Li YF; Yan LX; Dong ZY; He XF
BMC Cancer; 2018 May; 18(1):511. PubMed ID: 29720116
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Role of Tumor-Infiltrating Lymphocytes in Esophagus Cancer: a Meta-Analysis.
Zheng X; Song X; Shao Y; Xu B; Hu W; Zhou Q; Chen L; Zhang D; Wu C; Jiang J
Cell Physiol Biochem; 2018; 45(2):720-732. PubMed ID: 29414812
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis.
Gao G; Wang Z; Qu X; Zhang Z
BMC Cancer; 2020 Mar; 20(1):179. PubMed ID: 32131780
[TBL] [Abstract][Full Text] [Related]
6. The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis.
Gooden MJ; de Bock GH; Leffers N; Daemen T; Nijman HW
Br J Cancer; 2011 Jun; 105(1):93-103. PubMed ID: 21629244
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis.
Zhao Y; Ge X; He J; Cheng Y; Wang Z; Wang J; Sun L
World J Surg Oncol; 2019 May; 17(1):85. PubMed ID: 31118034
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of the common tumour-infiltrating lymphocyte subtypes for patients with non-small cell lung cancer: A meta-analysis.
Chen B; Li H; Liu C; Xiang X; Wang S; Wu A; Shen Y; Li G
PLoS One; 2020; 15(11):e0242173. PubMed ID: 33170901
[TBL] [Abstract][Full Text] [Related]
9. Effects of B7-H3 expression on tumour-infiltrating immune cells and clinicopathological characteristics in non-small-cell lung cancer.
Yim J; Koh J; Kim S; Song SG; Ahn HK; Kim YA; Jeon YK; Chung DH
Eur J Cancer; 2020 Jul; 133():74-85. PubMed ID: 32447027
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer.
Li J; Wang J; Chen R; Bai Y; Lu X
Oncotarget; 2017 Feb; 8(9):15621-15631. PubMed ID: 28152503
[TBL] [Abstract][Full Text] [Related]
11. Superpixel image segmentation of VISTA expression in colorectal cancer and its relationship to the tumoral microenvironment.
Wu D; Hacking S; Vitkovski T; Nasim M
Sci Rep; 2021 Aug; 11(1):17426. PubMed ID: 34465822
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and predictive value of tumor-infiltrating lymphocytes for clinical therapeutic research in patients with non-small cell lung cancer.
Zeng DQ; Yu YF; Ou QY; Li XY; Zhong RZ; Xie CM; Hu QG
Oncotarget; 2016 Mar; 7(12):13765-81. PubMed ID: 26871598
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Role of Tumor-Infiltrating Lymphocytes in Lung Cancer: a Meta-Analysis.
Geng Y; Shao Y; He W; Hu W; Xu Y; Chen J; Wu C; Jiang J
Cell Physiol Biochem; 2015; 37(4):1560-71. PubMed ID: 26513143
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic and prognostic significance of tumor-infiltrating CD8+ T cells in patients with hepatocellular carcinoma: A meta-analysis.
Xu X; Tan Y; Qian Y; Xue W; Wang Y; Du J; Jin L; Ding W
Medicine (Baltimore); 2019 Jan; 98(2):e13923. PubMed ID: 30633166
[TBL] [Abstract][Full Text] [Related]
15. VISTA expressed in tumour cells regulates T cell function.
Mulati K; Hamanishi J; Matsumura N; Chamoto K; Mise N; Abiko K; Baba T; Yamaguchi K; Horikawa N; Murakami R; Taki M; Budiman K; Zeng X; Hosoe Y; Azuma M; Konishi I; Mandai M
Br J Cancer; 2019 Jan; 120(1):115-127. PubMed ID: 30382166
[TBL] [Abstract][Full Text] [Related]
16. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of tumor PD-L1 expression combined with CD8
Wang Q; Lou W; Di W; Wu X
Int Immunopharmacol; 2017 Nov; 52():7-14. PubMed ID: 28846888
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis.
Ibrahim EM; Al-Foheidi ME; Al-Mansour MM; Kazkaz GA
Breast Cancer Res Treat; 2014 Dec; 148(3):467-76. PubMed ID: 25361613
[TBL] [Abstract][Full Text] [Related]
19. Association between LKB1 expression and prognosis of patients with solid tumours: an updated systematic review and meta-analysis.
Ren YH; Zhao FJ; Mo HY; Jia RR; Tang J; Zhao XH; Wei JL; Huo RR; Li QQ; You XM
BMJ Open; 2019 Aug; 9(8):e027185. PubMed ID: 31383697
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis.
Mao Y; Qu Q; Chen X; Huang O; Wu J; Shen K
PLoS One; 2016; 11(4):e0152500. PubMed ID: 27073890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
